Adicet Bio, Inc.
ACET
$0.57
$0.035.75%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.10M | 3.97M | 7.07M | 7.47M | 6.90M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.95M | 32.39M | 29.89M | 30.74M | 33.15M |
| Operating Income | -27.95M | -32.39M | -29.89M | -30.74M | -33.15M |
| Income Before Tax | -26.86M | -31.22M | -28.21M | -28.73M | -30.48M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -26.86M | -31.22M | -28.21M | -28.73M | -30.48M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -26.86M | -31.22M | -28.21M | -28.73M | -30.48M |
| EBIT | -27.95M | -32.39M | -29.89M | -30.74M | -33.15M |
| EBITDA | -26.38M | -30.74M | -28.21M | -29.12M | -31.56M |
| EPS Basic | -0.29 | -0.34 | -0.31 | -0.32 | -0.34 |
| Normalized Basic EPS | -0.18 | -0.21 | -0.19 | -0.20 | -0.21 |
| EPS Diluted | -0.29 | -0.34 | -0.31 | -0.32 | -0.34 |
| Normalized Diluted EPS | -0.18 | -0.21 | -0.19 | -0.20 | -0.21 |
| Average Basic Shares Outstanding | 91.09M | 91.09M | 91.07M | 90.85M | 90.85M |
| Average Diluted Shares Outstanding | 91.09M | 91.09M | 91.07M | 90.85M | 90.85M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |